CONMED Corp — Director's Dealing 2012

Mar 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-03-02

Reporting Person: DANIELS BRUCE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-02	Common Stock	M	1000	$16.46	Acquired	2400	Direct
2012-03-02	Common Stock	F	567	$29.04	Disposed	1833	Direct
2012-03-02	Common Stock	M	1000	$19.26	Acquired	2833	Direct
2012-03-02	Common Stock	F	664	$29.04	Disposed	2169	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-02	Sars (Stock Appreciation Rights)	$16.46	M	1000	Disposed	2019-06-01	Common Stock (1000)	Direct
2012-03-02	Sars (Stock Appreciation Rights)	$19.26	M	1000	Disposed	2020-06-01	Common Stock (1000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 20% per year over a five year period, with any unvested SARs to vest upon the Director's termination of service provided the Director has completed one full year of service since the date of the award in which case the SARS shall be exercisable at any time prior to the expiration date of the SAR or within one year after the date of such termination, whichever period is shorter.

F2: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.